• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ANIK

ANIK

Anika Therapeutics, Inc.

NASDAQHealthcareMedical - DevicesUS

USD14.41

+0.03 (+0.21%)

Rating:C+

Company Profile

CEO

Stephen D. Griffin

IPO Date

1993-05-03

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$14.45

Prev. Close

$14.38

Day Low

$14.20

Day High

$14.51

52W Low

$7.87

52W High

$16.24

Market Cap

$0.19B

Volume

0.05M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

4.3%

Avg Negative

5.5%

Avg Neutral

90.1%

News Feed

Anika Therapeutics' (ANIK) CEO Cheryl Blanchard on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/7/2021·↓ negative

Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021

GlobeNewsWire·7/19/2021·↑ positive

Anika to Host its 2021 Virtual Investor Day on June 3, 2021

GlobeNewsWire·5/13/2021·↑ positive

Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

Anika Therapeutics (ANIK) Surpasses Q1 Earnings and Revenue Estimates

Zacks Investment Research·5/6/2021·↑ positive

Anika to Issue First Quarter 2021 Financial Results on Thursday, May 6, 2021

GlobeNewsWire·4/15/2021·↑ positive

Anika to Participate in the 20th Annual Needham Virtual Healthcare Conference

GlobeNewsWire·4/5/2021·↑ positive

Anika to Participate in the Sidoti Spring Virtual Investor Conference

GlobeNewsWire·3/11/2021·↑ positive

Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/4/2021·↓ negative

Anika Therapeutics (ANIK) Reports Q4 Loss, Lags Revenue Estimates

Zacks Investment Research·3/4/2021·↑ positive